Growth in this market is driven by the increasing number of ESRD patients, growing prevalence of diabetes & hypertension (major causes of kidney failure), preference for dialysis treatments over kidney transplants due to lack of donors, and initiatives taken by leading players to introduce advanced products & services.
The
report China Hemodialysis and Peritoneal Dialysis Market is projected to reach USD 7.4
billion by 2024 from USD 5.0 billion in 2019, at a CAGR of 8.5%.
Ask for PDF Brochure: -https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=150472097
The hemodialysis
services segment is expected to account for the second-largest share of the
China hemodialysis market, by type, in 2019
The
China hemodialysis market is broadly categorized into two segments, namely,
hemodialysis products and hemodialysis services market. The hemodialysis (HD)
products market include machines (center-use & home-use machines) &
consumables (dialyzers, access products, bloodlines, dialysates, and other
consumables). The hemodialysis services (including in-center & home-
hemodialysis services) segment is expected to account for the largest share of
the China dialysis market. An increasing number of dialysis centers coupled
with the growing prevalence of ESRD is the major factor driving the growth of
the hemodialysis services market in China.
Automated peritoneal
dialysis is to register the highest CAGR in the China peritoneal dialysis
modality market during the forecast period
The
peritoneal dialysis market, by modality, includes continuous ambulatory
peritoneal dialysis (CAPD) and automated peritoneal dialysis (APD). The
APD segment is expected to grow at the fastest CAGR owing to its several
advantages over CAPD—daytime freedom for patients, fewer connections and
disconnections (and hence a lower probability of peritonitis), and improved
quality of life. Being automated, APD is preferred for dialysis treatment in
the elderly and children.
Request for Sample Pages: - https://www.marketsandmarkets.com/requestsampleNew.asp?id=150472097
The
major players operating in the China hemodialysis and peritoneal dialysis
market are Fresenius Medical Care AG & Co. KGaA (Germany), Baxter
International, Inc. (US) and Shandong Weigao Group Medical Polymer Company
Limited (China). Other players in this market include B. Braun Melsungen AG
(Germany), Nikkiso Co. Ltd. (Japan), DaVita Healthcare Partners, Inc (US),
Asahi Kasei Medical Co., Ltd (Japan), Bain Medical Equipment Co.,
Ltd. (China), Huaren Pharmaceutical (China), and Jiangsu Lengthen Life
Science and Technology Co. Ltd (China)
No comments:
Post a Comment